Encompass Health Corporation (EHC) Tops Q3 EPS by 9c; offers guidance

Encompass Health Corporation (NYSE: EHC) reported Q3 EPS of $1.03, $0.09 better than the analyst estimate of $0.94. Revenue for the quarter came in at $1.35 billion versus the consensus estimate of $1.33 billion.

GUIDANCE:

Encompass Health Corporation sees FY2024 EPS of $4.19-$4.33, versus the consensus of $4.19. Encompass Health Corporation sees FY2024 revenue of $5.325-5.375 billion, versus the consensus of $5.316 billion.

For earnings history and earnings-related data on Encompass Health Corporation (EHC) click here.

You May Also Be Interested In

• OneMain (OMF) Reiterated at Market Outperform by Citizens on Updated Estimates
• Sionna Therapeutics (SION) Reiterated at Market Outperform by Citizens: Readouts Upcoming
• SEACOR Marine acknowledges letter from shareholder Pointillist